FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Per Bech

Research Profile

Disorders

Activities & Behaviors

Questionnaires

Procedures

Concepts & Ideas

Geographic Areas

Denmark

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Per Bech
Autism as the clinical core marker in schizophrenia.
Per Bech
Facts and fictions in clinical psychiatry.
Per Bech; Ellen Margrethe Christensen; Klaus Martiny; Søren Dinesen Ostergaard; Maj Vinberg (former christensen); Lars Vedel Kessing
The Performance of the Revised Major Depression Inventory for Self-Reported Severity of Depression - Implications for the DSM-5 and ICD-11.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Per Bech (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Per Bech
Autism as the clinical core marker in schizophrenia.
World psychiatry : official journal of the World Psychiatric Association (WPA) 2013;12(1):81.
2013: Per Bech
Facts and fictions in clinical psychiatry.
Nordic journal of psychiatry 2013;67(1):13-4.
2013: Per Bech; Ellen Margrethe Christensen; Klaus Martiny; Søren Dinesen Ostergaard; Maj Vinberg (former christensen); Lars Vedel Kessing
The Performance of the Revised Major Depression Inventory for Self-Reported Severity of Depression - Implications for the DSM-5 and ICD-11.
Psychotherapy and psychosomatics 2013;82(3):187-8.
2012: Per Bech; L F Gram; J K Larsen; K B Stage; P Vestergaard
The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine.
Journal of affective disorders 2012;140(3):253-9.
2012: Klaus Martiny; Else Refsgaard; Lene Sørensen; Britta Thougaard; Lone Lindberg; Vibeke Lund; Marianne Lunde; Per Bech
A 9-week randomized trial comparing a chronotherapeutic intervention (wake and light therapy) to exercise in major depressive disorder patients treated with duloxetine.
The Journal of clinical psychiatry 2012;73(9):1234-42.
2012: Søren Dinesen Østergaard; Jim Bille; Nils Lauge; Henrik Søltoft-Jensen; Per Bech
The validity of the severity-psychosis hypothesis in depression.
Journal of affective disorders 2012;140(1):48-56.
2012: Per Bech
Subjective positive well-being.
World psychiatry : official journal of the World Psychiatric Association (WPA) 2012;11(2):105-6.
2012: Per Bech
The three-fold Hamilton Depression Scale: an editorial comment to Isacsson G, Adler M. Randomized clinical trials underestimate the efficacy of antidepressants in less severe depression (1).
Acta psychiatrica Scandinavica 2012;125(6):423-4.
2012: Klaus Martiny; Per Bech; Marianne Lunde; Per Plenge
A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression.
Nordic journal of psychiatry 2012;66(3):147-54.
2012: Per Bech; M Fava; M H Trivedi; S R Wisniewski; A J Rush
Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.
Acta psychiatrica Scandinavica 2012;125(4):342-8.
2012: Per Bech; G Bech-Andersen; E M Christensen; M Vinberg; Lars Vedel Kessing
Psychometric validation and clinical validity of the Minor Melancholia Mood Checklist (MMCL-32).
Journal of affective disorders 2012;137(1-3):79-86.
2012: Per Bech
Mood and anxiety in the medically ill.
Advances in psychosomatic medicine 2012;32():118-32.
2011: Ingelise Andersen; Per Bech; Else Nygaard; Karsten Thielen; Finn Diderichsen
Increasing prevalence of depression from 2000 to 2006.
Scandinavian journal of public health 2011;39(8):857-63.
2011: S D Ostergaard; S O W Jensen; Per Bech
The heterogeneity of the depressive syndrome: when numbers get serious.
Acta psychiatrica Scandinavica 2011;124(6):495-6.
2011: Per Bech; E M Christensen; M Vinberg; G Bech-Andersen; Lars Vedel Kessing
From items to syndromes in the Hypomania Checklist (HCL-32): psychometric validation and clinical validity analysis.
Journal of affective disorders 2011;132(1-2):48-54.
2011: Per Bech; Per Tanghøj; K Andreasson; K F Overø
Dose-response relationship of sertindole and haloperidol using the pharmacopsychometric triangle.
Acta psychiatrica Scandinavica 2011;123(2):154-61.
2011: Per Bech; M Gefke; L Lauritzen; Marianne Lunde; Klaus Martiny
The Pharmacopsychometric Triangle to Illustrate the Effectiveness of T-PEMF Concomitant with Antidepressants in Treatment Resistant Patients: A Double-Blind, Randomised, Sham-Controlled Trial Revisited with Focus on the Patient-Reported Outcomes.
Depression research and treatment 2011;2011():806298.
2010: K Andreasson; V Liest; Marianne Lunde; Klaus Martiny; M Unden; S Dissing; Per Bech
Identifying patients with therapy-resistant depression by using factor analysis.
Pharmacopsychiatry 2010;43(7):252-6.
2010: Per Bech; Sara L Lönn; Kerstin F Overø
Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
The Journal of clinical psychiatry 2010;71(2):121-9.
2010: Bo Netterstrøm; Per Bech
Effect of a multidisciplinary stress treatment programme on the return to work rate for persons with work-related stress. A non-randomized controlled study from a stress clinic.
BMC public health 2010;10():658.
2009: Per Bech; Lise Gormsen; Dorte Loldrup; Marianne Lunde
The clinical effect of clomipramine in chronic idiopathic pain disorder revisited using the Spielberger State Anxiety Symptom Scale (SSASS) as outcome scale.
Journal of affective disorders 2009;119(1-3):43-51.
2009: Per Bech
Applied psychometrics in clinical psychiatry: the pharmacopsychometric triangle.
Acta psychiatrica Scandinavica 2009;120(5):400-9.
2009: Klaus Martiny; Marianne Lunde; Mogens Undén; Henrik Dam; Per Bech
High cortisol awakening response is associated with an impairment of the effect of bright light therapy.
Acta psychiatrica Scandinavica 2009;120(3):196-202.
2009: K Thielen; E Nygaard; Ingelise Andersen; R Rugulies; E Heinesen; Per Bech; U Bültmann; Finn Diderichsen
Misclassification and the use of register-based indicators for depression.
Acta psychiatrica Scandinavica 2009;119(4):312-9.
2009: Per Bech; P Wilson; T Wessel; Marianne Lunde; M Fava
A validation analysis of two self-reported HAM-D6 versions.
Acta psychiatrica Scandinavica 2009;119(4):298-303.
2009: Per Bech
Fifty years with the Hamilton scales for anxiety and depression. A tribute to Max Hamilton.
Psychotherapy and psychosomatics 2009;78(4):202-11.
2008: L G Bretlau; Marianne Lunde; L Lindberg; Mogens Undén; S Dissing; Per Bech
Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
Pharmacopsychiatry 2008;41(2):41-7.
2007: Per Bech
Dose-response relationship of pregabalin in patients with generalized anxiety disorder. A pooled analysis of four placebo-controlled trials.
Pharmacopsychiatry 2007;40(4):163-8.
2007: Peter Winning Jepsen; Knud Juel; Per Bech
[A 50-year register follow-up of 112 patients with a classic diagnosis of neurosis].
Ugeskrift for laeger 2007;169(18):1678-82.
2007: Lis Raabaek Olsen; Povl Munk-Jørgensen; Per Bech
[The prevalence of depression in Denmark].
Ugeskrift for laeger 2007;169(16):1425-6.
2007: Maj Vinberg (former christensen); Per Bech; Kirsten Ohm Kyvik; Lars Vedel Kessing
Quality of life in unaffected twins discordant for affective disorder.
Journal of affective disorders 2007;99(1-3):133-8.
2007: Vibeke Nørholm; Per Bech
Quality of life assessment in schizophrenia: applicability of the Lehman Quality of Life Questionnaire (TL-30).
Nordic journal of psychiatry 2007;61(6):438-42.
2007: Per Bech; Marianne Lunde; G Bech-Andersen; L Lindberg; Klaus Martiny
Psychiatric outcome studies (POS): does treatment help the patients? A Popperian approach to research in clinical psychiatry.
Nordic journal of psychiatry 2007;61 Suppl 46():4-34.
2006: Lars Vedel Kessing; Per Bech
[Screening and case finding instruments for depression--results from a Cochrane review].
Ugeskrift for laeger 2006;168(40):3412-5.
2006: Per Bech; Daniel K Kajdasz; Vibeke Porsdal
Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder.
Psychopharmacology 2006;188(3):273-80.
2006: Klaus Martiny; Marianne Lunde; Mogens Undén; Henrik Dam; Per Bech
The lack of sustained effect of bright light, after discontinuation, in non-seasonal major depression.
Psychological medicine 2006;36(9):1247-52.
2006: Per Bech; Henning Friis Andersen; Alan Wade
Effective dose of escitalopram in moderate versus severe DSM-IV major depression.
Pharmacopsychiatry 2006;39(4):128-34.
2006: Per Bech; J Bille; S Waarst; M Wiese; L Borberg; P Treufeldt; Lars Vedel Kessing
Validity of HoNOS in identifying frequently hospitalized patients with ICD-10 mental disorders.
Acta psychiatrica Scandinavica 2006;113(6):485-91.
2006: Lis Raabaek Olsen; EL Mortensen; Per Bech
Mental distress in the Danish general population.
Acta psychiatrica Scandinavica 2006;113(6):477-84.
2006: Lars Vedel Kessing; Hanne Vibe Hansen; Mirella Ruggeri; Per Bech
Satisfaction with treatment among patients with depressive and bipolar disorders.
Social psychiatry and psychiatric epidemiology 2006;41(2):148-55.
2006: Per Bech; Hanne Vibe Hansen; Lars Vedel Kessing
The internalising and externalising dimensions of affective symptoms in depressed (unipolar) and bipolar patients.
Psychotherapy and psychosomatics 2006;75(6):362-9.
2006: Per Bech
Rating scales in depression: limitations and pitfalls.
Dialogues in clinical neuroscience 2006;8(2):207-15.
2006: M P Søndergaard; J O Jarden; Klaus Martiny; G Andersen; Per Bech
Dose response to adjunctive light therapy in citalopram-treated patients with post-stroke depression. A randomised, double-blind pilot study.
Psychotherapy and psychosomatics 2006;75(4):244-8.
2006: Lars Vedel Kessing; Hanne Vibe Hansen; Per Bech
Attitudes and beliefs among patients treated with mood stabilizers.
Clinical practice and epidemiology in mental health : CP & EMH 2006;2():8.
2006: Per Bech; Marianne Gex-Fabry; Jean-Michel Aubry; S Favre; Gilles Bertschy
Olanzapine plasma level in relation to antimanic effect in the acute therapy of manic states.
Nordic journal of psychiatry 2006;60(2):181-2.
2006: Lars Vedel Kessing; Hanne Vibe Hansen; Per Bech
General health and well-being in outpatients with depressive and bipolar disorders.
Nordic journal of psychiatry 2006;60(2):150-6.
2006: Vibeke Nørholm; Per Bech
Quality of life in schizophrenic patients: association with depressive symptoms.
Nordic journal of psychiatry 2006;60(1):32-7.
2005: Lars Vedel Kessing; Hanne Vibe Hansen; Koen Demyttenaere; Per Bech
Depressive and bipolar disorders: patients' attitudes and beliefs towards depression and antidepressants.
Psychological medicine 2005;35(8):1205-13.
2005: Klaus Martiny; Marianne Lunde; Mogens Undén; Henrik Dam; Per Bech
Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales.
Acta psychiatrica Scandinavica 2005;112(2):117-25.
2005: Klaus Martiny; Marianne Lunde; Mogens Undén; Henrik Dam; Per Bech
Adjunctive bright light in non-seasonal major depression: results from patient-reported symptom and well-being scales.
Acta psychiatrica Scandinavica 2005;111(6):453-9.
2005: Rasmus W Licht; Susanne Qvitzau; P Allerup; Per Bech
Validation of the Bech-Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression; is the total score a valid measure of illness severity?
Acta psychiatrica Scandinavica 2005;111(2):144-9.
2005: NA Rasmussen; P Schrøder; Lis Raabaek Olsen; M Brødsgaard; Mogens Undén; Per Bech
Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92).
Nordic journal of psychiatry 2005;59(3):173-8.
2005: T H Andersen; Per Bech; N-E Larsen
Switching patients from olanzapine or risperidone to a combination treatment using perphenazine plus buspirone: evaluation of antipsychotic efficacy and side-effects, including extrapyramidal effects and weight loss.
Nordic journal of psychiatry 2005;59(3):205-8.
2005: Per Bech
Social functioning: should it become an endpoint in trials of antidepressants?
CNS drugs 2005;19(4):313-24.
2004: Per Bech; Per Tanghøj; Philippe Cialdella; Henning Friis Andersen; Anders Gersel Pedersen
Escitalopram dose-response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2004;7(3):283-90.
2004: Lis Raabaek Olsen; EL Mortensen; Per Bech
The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample.
Acta psychiatrica Scandinavica 2004;110(3):225-9.
2004: Klaus Martiny; Christian Simonsen; Marianne Lunde; Lars Clemmensen; Per Bech
Decreasing TSH levels in patients with Seasonal Affective Disorder (SAD) responding to 1 week of bright light therapy.
Journal of affective disorders 2004;79(1-3):253-7.
2004: V Noerholm; Mogens Groenvold; Torquil Watt; Jakob B Bjorner; NA Rasmussen; Per Bech
Quality of life in the Danish general population--normative data and validity of WHOQOL-BREF using Rasch and item response theory models.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2004;13(2):531-40.
2004: Klaus Martiny; Marianne Lunde; C Simonsen; L Clemmensen; Dorte Loldrup Poulsen; Kim Solstad; Per Bech
Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study.
Acta psychiatrica Scandinavica 2004;109(3):230-4.
2004: Lis Raabaek Olsen; EL Mortensen; Per Bech
Prevalence of major depression and stress indicators in the Danish general population.
Acta psychiatrica Scandinavica 2004;109(2):96-103.
2003: J Bent-Hansen; Marianne Lunde; R Klysner; M Andersen; Per Tanghøj; Kim Solstad; Per Bech
The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression.
Pharmacopsychiatry 2003;36(6):313-6.
2003: Per Bech; R Lucas; M Amir; D Bushnell; M Martin; D Buesching
Association between clinically depressed subgroups, type of treatment and patient retention in the LIDO study.
Psychological medicine 2003;33(6):1051-9.
2003: Per Bech; Robert Moses; Ramón Gomis
The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve Type 2 diabetes: a placebo-controlled, multicentre study.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2003;12(4):413-25.
2003: Alice Rasmussen; Marianne Lunde; Dorte Loldrup Poulsen; Karen Sørensen; Susanne Qvitzau; Per Bech
A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients.
Psychosomatics 2003;44(3):216-21.
2003: Per Bech
18-month maintenance treatment with sertraline may have sustained psychosocial benefits in chronic depression.
Evidence-based mental health 2003;6(2):49.
2003: Lis Raabaek Olsen; D V Jensen; V Noerholm; Klaus Martiny; Per Bech
The internal and external validity of the Major Depression Inventory in measuring severity of depressive states.
Psychological medicine 2003;33(2):351-6.
2003: Per Bech; Jim Bille; Thomas Schütze; Susan Søndergaard; Marianne Wiese; Søren Waarst
Health of the Nation Outcome Scales (HoNOS): Implementability, subscale structure and responsiveness in the daily psychiatric hospital routine over the first 18 months.
Nordic journal of psychiatry 2003;57(4):285-90.
2003: Per Bech; Lis Raabaek Olsen; Mette Kjoller; niels rasmussen
Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale.
International journal of methods in psychiatric research 2003;12(2):85-91.
2002: Per Bech; Per Tanghøj; Henning Friis Andersen; K Overø
Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
Psychopharmacology 2002;163(1):20-5.
2002: Per Bech
The Bech-Rafaelsen Mania Scale in clinical trials of therapies for bipolar disorder: a 20-year review of its use as an outcome measure.
CNS drugs 2002;16(1):47-63.
2001: Per Bech
Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2001;4(4):337-45.
2001: Per Bech; NA Rasmussen; Lis Raabaek Olsen; V Noerholm; W Abildgaard
The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity.
Journal of affective disorders 2001;66(2-3):159-64.
2001: Per Bech; P C Baastrup; E de Bleeker; R Ropert
Dimensionality, responsiveness and standardization of the Bech-Rafaelsen Mania Scale in the ultra-short therapy with antipsychotics in patients with severe manic episodes.
Acta psychiatrica Scandinavica 2001;104(1):25-30.
2001: Vibeke Nørholm; Per Bech
The WHO Quality of Life (WHOQOL) Questionnaire: Danish validation study.
Nordic journal of psychiatry 2001;55(4):229-35.
2001: T Schuetze; Vibeke Nørholm; L Raabaek Olsen; H Hougaard; M Ekstrøm; P Wagn; Per Bech
Reliability and validity of the Danish version of the Calgary Depression Scale for Schizophrenia.
Nordic journal of psychiatry 2001;55(2):119-22.
2000: Torquil Watt; Mogens Groenvold; Jakob B Bjorner; V Noerholm; NA Rasmussen; Per Bech
Fatigue in the Danish general population. Influence of sociodemographic factors and disease.
Journal of epidemiology and community health 2000;54(11):827-33.
2000: N Becker; Per Sjøgren; Per Bech; Aage Kristian Olsen; Jørgen Eriksen
Treatment outcome of chronic non-malignant pain patients managed in a danish multidisciplinary pain centre compared to general practice: a randomised controlled trial.
Pain 2000;84(2-3):203-11.
1999: Per Bech
Health-related quality of life measurements in the assessment of pain clinic results.
Acta anaesthesiologica Scandinavica 1999;43(9):893-6.
1999: Per Bech; L Raabaek Olsen; N Jarløv; M Hammer; T Schütze; L Breum
A case of sequential anti-stress medication in a patient with major depression resistant to amine-reuptake inhibitors.
Acta psychiatrica Scandinavica 1999;100(1):76-8.
1999: Mogens Groenvold; P M Fayers; M A Sprangers; Jakob B Bjorner; Marianne C Klee; N K Aaronson; Per Bech; Henning T Mouridsen
Anxiety and depression in breast cancer patients at low risk of recurrence compared with the general population: a valid comparison?
Journal of clinical epidemiology 1999;52(6):523-30.
1998: N Becker; Annemarie Bondegaard Thomsen; Aage Kristian Olsen; Per Sjøgren; Per Bech; Jørgen Eriksen
[Pain epidemiology and health-related quality of life in patients with chronic non-malignant pain].
Ugeskrift for laeger 1998;160(47):6816-9.
1998: Jakob B Bjorner; Svend Kreiner; John Ware; Mogens Trab Damsgaard; Per Bech
Differential item functioning in the Danish translation of the SF-36.
Journal of clinical epidemiology 1998;51(11):1189-202.
1998: Jakob B Bjorner; K Thunedborg; Tage S Kristensen; Jens Modvig; Per Bech
The Danish SF-36 Health Survey: translation and preliminary validity studies.
Journal of clinical epidemiology 1998;51(11):991-9.
1998: Per Bech; J C Peuskens; S R Marder; G Chouinard; O J Høyberg; M O Huttunen; O Blin; A Claus
Meta-analytic study of the benefits and risks of treating chronic schizophrenia with risperidone or conventional neuroleptics.
European psychiatry : the journal of the Association of European Psychiatrists 1998;13(6):310-4.
1998: J Dam; L Ryde; J Svejsø; N Lauge; B Lauritsen; Per Bech
Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
Pharmacopsychiatry 1998;31(2):48-54.